Skip to content

    Recently Viewed


      Scios Inc. Announces Agreement with Department of Justice Regarding NATRECOR®

      Share Article
      share to

      Raritan, NJ (October 5, 2011) – Today Scios Inc. announced an agreement with the United States Department of Justice to resolve allegations of misbranding of NATRECOR® (nesiritide), a prescription medication for patients with heart failure.

      As part of this agreement, Scios Inc. entered a guilty plea to a single misdemeanor violation of the Food, Drug and Cosmetic Act, and agreed to pay an $85 million fine.

      Scios acknowledges that NATRECOR® was misbranded and used in a way not approved by the U.S. Food and Drug Administration because its labeling lacked adequate directions for that use, but denies any wrongful intent in connection with this plea.


      Shaun Mickus
      Office: (908) 927-2416

      Bill Foster
      Cell: (908) 392-6057

      You are now leaving and going to a site with a different privacy policy. Please click below to continue to that site.